Tag: Asterion Cannabis Inc.

May 29, 2019

Asterion Appoints John Wagner as Strategic Advisor

Asterion Cannabis Inc. ("Asterion" or the "Company") and Asterion Australia Pty Ltd ("Asterion Australia"), the Company's wholly-owned subsidiary, announces that...
May 16, 2019

Asterion Invited to Participate in the Cowen Toronto Cannabis Summit

Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company"), announces that it will be attending the Cowen Toronto Cannabis Summit on...
May 6, 2019

Asterion Announces $25 Million Private Placement

Asterion Cannabis Inc. ("Asterion" or the "Company"), announces a non-brokered private placement of up to 20,000,000 units (each, a "Unit") at...
April 24, 2019

Asterion Signs Land Purchase Agreement for 75 Hectares of Land for its Queensland Medicinal Cannabis Facility

Asterion Cannabis Inc. (“Asterion” or the “Company”), announces that, further to its news release dated February 4, 2019, the Company’s wholly-owned...
April 4, 2019

Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project

Asterion Cannabis Inc. (P.ASTR) ("Asterion") and PreveCeutical Medical Inc. ("PreveCeutical") (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announce today that Asterion's wholly-owned Australian subsidiary, Asterion Australia Pty Ltd,...
March 5, 2019

Asterion Signs Research Agreement with the University of Queensland for Clonal Propagation of Cannabis Plants

Asterion Cannabis Inc. (P.ASTR) ("Asterion" or the "Company") announces that its wholly-owned Australian subsidiary has entered into a collaborative research contract with...
February 6, 2019

Asterion Files an Application for Medicinal Cannabis Licenses from the Australian Office of Drug Control

Asterion Cannabis Inc. ("Asterion" or the "Company"), announces that on December 19, 2018, the Company's wholly-owned Australian subsidiary ("Asterion Australia"), filed...